The prevalence and predictors of type two diabetes mellitus in people with schizophrenia: a systematic review and comparative meta‐analysis
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Objective: To conduct a meta‐analysis investigating the prevalence of type two diabetes mellitus (T2 DM) in people with schizophrenia compared to controls. Method: Systematic review of electronic databases from inception till November 2014. Articles reporting the prevalence of T2 DM in people with schizophrenia and healthy controls (without mental illness) were included. Two independent authors conducted searches and extracted data. A random effects relative risks (RR) meta‐analysis was conducted. Results: Twenty‐five studies including 145 718 individuals with schizophrenia (22.5–54.4 years) and 4 343 407 controls were included. The prevalence of T2 DM in people with schizophrenia was 9.5% (95% CI = 7.0–12.8, n = 145 718) and 10.75% (95% CI 7.44–14.5%, n = 2698) in studies capturing T2 DM according to recognized criteria. The pooled RR across all studies was 1.82 (95% CI = 1.56–2.13; = 4 489 125). Subgroup analyses found a RR of 2.53 (95% CI = 1.68–3.799, n = 17 727) in studies ascertaining T2 DM according to recognized criteria and RR 1.65 (95% CI = 1.34–2.03, n = 4 243 389) in studies relying on T2 DM determined through medical records. Conclusion: People with schizophrenia are at least double the risk of developing T2 DM according to recognized T2 DM criteria. Proactive lifestyle and screening programmes should be given clinical priority.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International physical activity questionnaire: 12-country reliability and validity
CRAIG, C. L., MARSHALL, A. L., SJ??STR??M, M., BAUMAN, A. E., BOOTH, M. L., AINSWORTH, B. E., PRATT, M., EKELUND, U., YNGVE, A., SALLIS, J. F., et al. (2003) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000078924.61453.fb · Cited by 21,619
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.005 · Cited by 19,575
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
The Emerging Risk Factors Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)60484-9 · Cited by 5,125
DE HERT, M., CORRELL, C. U., BOBES, J., CETKOVICH‐BAKMAS, M., COHEN, D., ASAI, I., DETRAUX, J., GAUTAM, S., MÖLLER, H., NDETEI, D. M., et al. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00014.x · Cited by 2,488 · cited 1×
“Psychiatrists are well placed to coordinate the T2DM risk assessment and management; ideally, this should be part of an integrated programme including primary care physicians and endocrinologists (50, 51).”
BackgroundSaha, S., Chant, D., & McGrath, J. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.10.1123 · Cited by 2,065
Wilmot, E. G., Edwardson, C. L., Achana, F. A., Davies, M. J., Gorely, T., Gray, L. J., Khunti, K., Yates, T., & Biddle, S. J. H. (2012) · Diabetologia · doi:10.1007/s00125-012-2677-z · Cited by 1,789
De Hert, M., Dekker, J. M., Wood, D., Kahl, K. G., Holt, R. I. G., & Möller, H.-J. (2009) · European Psychiatry · doi:10.1016/j.eurpsy.2009.01.005 · Cited by 951
DE HERT, M., COHEN, D., BOBES, J., CETKOVICH‐BAKMAS, M., LEUCHT, S., NDETEI, D. M., NEWCOMER, J. W., UWAKWE, R., ASAI, I., MÖLLER, H., et al. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00036.x · Cited by 870
Lawrence, D., Hancock, K. J., & Kisely, S. (2013) · BMJ · doi:10.1136/bmj.f2539 · Cited by 819
Cited by
Firth, J., Siddiqi, N., Koyanagi, A., Siskind, D., Rosenbaum, S., Galletly, C., Allan, S., Caneo, C., Carney, R., Carvalho, A. F., et al. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30132-4 · Cited by 1,531
Self-citationHjorthøj, C., Stürup, A. E., McGrath, J. J., & Nordentoft, M. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30078-0 · Cited by 1,304
Luchini, C., Stubbs, B., Solmi, M., & Veronese, N. (2017) · World Journal of Meta-Analysis · doi:10.13105/wjma.v5.i4.80 · Cited by 977
Self-citationRisk factors for type 2 diabetes mellitus: An exposure-wide umbrella review of meta-analyses
Bellou, V., Belbasis, L., Tzoulaki, I., & Evangelou, E. (2018) · PLOS ONE · doi:10.1371/journal.pone.0194127 · Cited by 713
Vancampfort, D., Correll, C. U., Galling, B., Probst, M., De Hert, M., Ward, P. B., Rosenbaum, S., Gaughran, F., Lally, J., & Stubbs, B. (2016) · World Psychiatry · doi:10.1002/wps.20309 · Cited by 659
Self-citationStubbs, B., Firth, J., Berry, A., Schuch, F. B., Rosenbaum, S., Gaughran, F., Veronesse, N., Williams, J., Craig, T., Yung, A. R., et al. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.05.017 · Cited by 379
Self-citationInternational trends in clozapine use: a study in 17 countries
Bachmann, C. J., Aagaard, L., Bernardo, M., Brandt, L., Cartabia, M., Clavenna, A., Coma Fusté, A., Furu, K., Garuoliené, K., Hoffmann, F., et al. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12742 · Cited by 314
How sedentary are people with psychosis? A systematic review and meta-analysis
Stubbs, B., Williams, J., Gaughran, F., & Craig, T. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.01.034 · Cited by 284
Self-citationVancampfort, D., Rosenbaum, S., Schuch, F. B., Ward, P. B., Probst, M., & Stubbs, B. (2016) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2015.11.008 · Cited by 225
Self-citationBora, E., Akdede, B. B., & Alptekin, K. (2017) · Psychological Medicine · doi:10.1017/s0033291716003366 · Cited by 219
“The prevalence of type 2 diabetes mellitus (DM) in schizophrenia is also double that of the general population (Stubbs et al. 2015).”
BackgroundDaré, L. O., Bruand, P.-E., Gérard, D., Marin, B., Lameyre, V., Boumédiène, F., & Preux, P.-M. (2019) · BMC Public Health · doi:10.1186/s12889-019-6623-6 · Cited by 197
Vancampfort, D., Mitchell, A. J., De Hert, M., Sienaert, P., Probst, M., Buys, R., & Stubbs, B. (2015) · Depression and Anxiety · doi:10.1002/da.22387 · Cited by 171
Self-citationStubbs, B., Thompson, T., Acaster, S., Vancampfort, D., Gaughran, F., & Correll, C. U. (2015) · Pain · doi:10.1097/j.pain.0000000000000304 · Cited by 141
“Research has consistently demonstrated that people with schizophrenia experience an increased number of painful physical health comorbidities, including fractures [48], diabetes [50] and cardiovascular diseases, such as myocardial infarction [19; 37].”
BackgroundSelf-citationLindekilde, N., Scheuer, S. H., Rutters, F., Knudsen, L., Lasgaard, M., Rubin, K. H., Henriksen, J. E., Kivimäki, M., Andersen, G. S., & Pouwer, F. (2022) · Diabetologia · doi:10.1007/s00125-021-05609-x · Cited by 119
Vancampfort, D., Rosenbaum, S., Ward, P. B., & Stubbs, B. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.09.029 · Cited by 113
“People with schizophrenia have consistently higher levels of premature mortality than the general population (Walker et al., 2015), mainly due to an increased risk of cardio-metabolic diseases (Stubbs et al., 2015; Vancampfort et al., 2013).”
BackgroundSelf-citationType 2 Diabetes Among People With Posttraumatic Stress Disorder: Systematic Review and Meta-Analysis
Vancampfort, D., Rosenbaum, S., Ward, P. B., Steel, Z., Lederman, O., Lamwaka, A. V., Richards, J. W., & Stubbs, B. (2016) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000297 · Cited by 97
Self-citationBarriers to effective diabetes management–a survey of people with severe mental illness
Mulligan, K., McBain, H., Lamontagne-Godwin, F., Chapman, J., Flood, C., Haddad, M., Jones, J., & Simpson, A. (2018) · BMC Psychiatry · doi:10.1186/s12888-018-1744-5 · Cited by 68
“Among the health disparities experienced is a two-fold risk of developing diabetes [3, 4], which has a prevalence of approximately 13% in people with SMI [5].”
BackgroundChronic pain diagnoses and opioid dispensings among insured individuals with serious mental illness
Owen-Smith, A., Stewart, C., Sesay, M. M., Strasser, S. M., Yarborough, B. J., Ahmedani, B., Miller-Matero, L. R., Waring, S. C., Haller, I. V., Waitzfelder, B. E., et al. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-2456-1 · Cited by 54
Are people with schizophrenia adherent to diabetes medication? A comparative meta-analysis
Gorczynski, P., Firth, J., Stubbs, B., Rosenbaum, S., & Vancampfort, D. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.01.049 · Cited by 37
Self-citationMorton, E., & Murray, G. (2020) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.2433 · Cited by 29
Roberts, E., Jones, L., Blackman, A., Dewhurst, T., Matcham, F., Kan, C., Mustafa, O., Thomas, T., Siddiqi, N., Ismail, K., et al. (2017) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2017.01.003 · Cited by 23
Metadata
- Authors
- Stubbs, B., Vancampfort, D., De Hert, M., & Mitchell, A. J.
- Venue
- Acta Psychiatrica Scandinavica
- Publisher
- Wiley
- Published
- 2015-05-05
- Volume
- 132
- Issue
- 2
- Pages
- 144-157
- ISSN
- 0001-690X (ISSN-L)
- 1600-0447
- OpenAlex
- W1721575563
- Cited by
- 238
- References
- 21
- FWCI
- 3.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.